Breast cancer patients to be evaluated for genetic testing

byVanderbilt University Medical CenterCredit: CC0 Public DomainAccording to a statement on behalf of the American College of Medical Genetics and Genomics (ACMG) published Dec. 13 in the organiz

Oncology December 22,2023

Breast cancer patients to be evaluated for genetic testing

byVanderbilt University Medical CenterCredit: CC0 Public DomainAccording to a statement on behalf of the American College of Medical Genetics and Genomics (ACMG) published Dec. 13 in the organiz

Oncology December 22,2023

WHO moves step closer to cheaper breast cancer treatment

The World Health Organization has approved a biosimilar version of Trastuzumab—the drug used to treat breast cancer—that is generally 65 percent cheaper than the originalThe World Health Organization

Oncology December 22,2023

WHO moves step closer to cheaper breast cancer treatment

The World Health Organization has approved a biosimilar version of Trastuzumab—the drug used to treat breast cancer—that is generally 65 percent cheaper than the originalThe World Health Organization

Oncology December 22,2023

Key genetic code change drives common lung cancer type

byNYU Langone HealthGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.11.015A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has i

Oncology December 22,2023

Key genetic code change drives common lung cancer type

byNYU Langone HealthGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.11.015A team led by researchers at NYU Langone Health's Perlmutter Cancer Center has i

Oncology December 22,2023

Breast cancer risk from menopause hormones may last decades

by Marilynn MarchioneIn this May 6, 2010 file photo, a radiologist checks mammograms in in Los Angeles. Women who use certain types of hormones after menopause still have an increased risk of developi

Oncology December 22,2023

Breast cancer risk from menopause hormones may last decades

by Marilynn MarchioneIn this May 6, 2010 file photo, a radiologist checks mammograms in in Los Angeles. Women who use certain types of hormones after menopause still have an increased risk of developi

Oncology December 22,2023

Free tool simplifies cancer research

byKarolinska InstitutetCredit: CC0 Public DomainEvery cell contains a vast number of proteins, each of which has a specific function, for example, as a receptor for another molecule or an enzyme

Oncology December 22,2023

Free tool simplifies cancer research

byKarolinska InstitutetCredit: CC0 Public DomainEvery cell contains a vast number of proteins, each of which has a specific function, for example, as a receptor for another molecule or an enzyme

Oncology December 22,2023

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

Oncology December 22,2023

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

Oncology December 22,2023

Pregnancy-related heart failure tied to higher cancer risk

(HealthDay)—Patients with peripartum cardiomyopathy (PPCM) are more likely to have cancer before PPCM diagnosis and more likely to develop cancer after PPCM, according to a study published in the Dece

OB & GYN December 22,2023

Pregnancy-related heart failure tied to higher cancer risk

(HealthDay)—Patients with peripartum cardiomyopathy (PPCM) are more likely to have cancer before PPCM diagnosis and more likely to develop cancer after PPCM, according to a study published in the Dece

OB & GYN December 22,2023

Shutting down backup genes leads to cancer remission in mice

by Jim Lynch,University of MichiganAbhinav Achreja, PhD, Research Fellow at the University of Michigan Biomedical Engineering and Deepak Nagrath, Ph.D. Associate Professor of Biomedical Engineer

Oncology December 22,2023

Shutting down backup genes leads to cancer remission in mice

by Jim Lynch,University of MichiganAbhinav Achreja, PhD, Research Fellow at the University of Michigan Biomedical Engineering and Deepak Nagrath, Ph.D. Associate Professor of Biomedical Engineer

Oncology December 22,2023

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Oncology December 22,2023

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Oncology December 22,2023

Dissemination of bone metastasis linked with bone remodeling

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainYears to decades after breast tumors have been removed, cancer may return or metastasize in other organs. Bone is frequently affected

Orthopedics & Sports medicine December 22,2023

Dissemination of bone metastasis linked with bone remodeling

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainYears to decades after breast tumors have been removed, cancer may return or metastasize in other organs. Bone is frequently affected

Orthopedics & Sports medicine December 22,2023